Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 3,036 |
|
|||||
| News | - | ||||||
| Day High | 0.7331 | Low High |
|||||
| Day Low | 0.665 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Virax Biolabs Group Ltd | VRAX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.00999 | -1.43% | 0.69001 | 17:00:01 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.681 | 0.665 | 0.7331 | 0.69001 | 0.70 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 54 | 3,036 | US$ 0.7051994 | US$ 2,141 | - | 0.6133 - 5.445 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:04:37 | 1 | US$ 0.68 | USD |
Virax Biolabs Group Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.07M | 1.56M | - | 9k | -5.46M | -3.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Virax Biolabs News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRAX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.69 | 0.739899 | 0.6133 | 0.6701572 | 12,722 | 0.00001 | 0.00% |
| 1 Month | 0.749 | 0.896855 | 0.6133 | 0.7644595 | 24,136 | -0.05899 | -7.88% |
| 3 Months | 0.7501 | 1.09 | 0.6133 | 0.86985 | 37,246 | -0.06009 | -8.01% |
| 6 Months | 2.42 | 2.80 | 0.6133 | 1.44 | 113,851 | -1.73 | -71.49% |
| 1 Year | 4.39 | 5.445 | 0.6133 | 3.13 | 168,677 | -3.70 | -84.28% |
| 3 Years | 200.00 | 290.00 | 0.6133 | 42.06 | 1,003,718 | -199.31 | -99.65% |
| 5 Years | 200.00 | 290.00 | 0.6133 | 42.06 | 1,003,718 | -199.31 | -99.65% |
Virax Biolabs Description
| Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus. |
